Suppr超能文献

新型脂霉素,可抑制细菌肽聚糖合成,由链霉菌产生。I. 产生菌及培养基成分。

New types of liposidomycins that inhibit bacterial peptidoglycan synthesis and are produced by Streptomyces. I. Producing organism and medium components.

作者信息

Kimura K, Kagami S, Ikeda Y, Takahashi H, Yoshihama M, Kusakabe H, Osada H, Isono K

机构信息

Research Institute of Life Science, Snow Brand Milk Products Co., Ltd., Tochigi, Japan.

出版信息

J Antibiot (Tokyo). 1998 Jul;51(7):640-6. doi: 10.7164/antibiotics.51.640.

Abstract

Liposidomycins are atypical lipid-bearing nucleoside antibiotics that inhibit bacterial peptidoglycan synthesis. A producing strain was identified as a Streptomyces sp. from its cultural characteristics and physiological properties. It produced new types of liposidomycins that lacked sulfate and/or 3-methylglutaric acid moieties present in known liposidomycins by changing medium components. Sucrose and malt extract were particularly suitable sources for specific production of the new types of liposidomycins.

摘要

脂糖霉素是一类非典型的含脂核苷抗生素,可抑制细菌肽聚糖的合成。根据其培养特性和生理特性,确定其产生菌为链霉菌属的一个菌株。通过改变培养基成分,该菌株产生了新型脂糖霉素,这些新型脂糖霉素缺乏已知脂糖霉素中存在的硫酸根和/或3-甲基戊二酸部分。蔗糖和麦芽提取物是特异性生产新型脂糖霉素的特别合适的来源。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验